Compare CAVA & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAVA | BRKR |
|---|---|---|
| Founded | 2006 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 7.3B |
| IPO Year | 2023 | 2000 |
| Metric | CAVA | BRKR |
|---|---|---|
| Price | $58.93 | $47.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | ★ $78.84 | $49.42 |
| AVG Volume (30 Days) | ★ 3.3M | 1.9M |
| Earning Date | 11-04-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | ★ 151.16 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | $1,132,074,000.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $24.00 | $3.55 |
| Revenue Next Year | $20.42 | $1.49 |
| P/E Ratio | $50.62 | ★ N/A |
| Revenue Growth | ★ 23.93 | 6.10 |
| 52 Week Low | $43.41 | $28.53 |
| 52 Week High | $144.49 | $64.64 |
| Indicator | CAVA | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 56.53 |
| Support Level | $51.52 | $47.52 |
| Resistance Level | $62.16 | $48.73 |
| Average True Range (ATR) | 2.10 | 1.56 |
| MACD | 0.51 | -0.09 |
| Stochastic Oscillator | 67.18 | 66.29 |
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.